Deep&Harmonicare IVF Center completed nearly 200 million baht of A+ rounds of financing，leading the assisted reproductive track！
On June 26, 2022, the A+ round financing signing ceremony and the global layout strategy conference were held in the lobby on the first floor of Deep&Harmonicare IVF Center, officially announcing the completion of the A+ round of strategic financing of nearly 200 million baht.
In this round of financing, Deep & Harmonicare IVF Center introduced LOFIS, a well-known investment company in Thailand, as a strategic investment institution. LOFIS Investment Group is a multinational investment group with strong investment strength and rich investment experience. Thai LOFIS has invested in many medical and health care, real estate, hotel, entertainment, and tourism projects in Thailand. The introduction of Lofis’ investment has far-reaching significance for Thailand’s DHC global strategic layout.
The funds will be used to further improve the global strategic layout of Deep & Harmonicare IVF Center, consolidate DHC Medical Group’s leading position in the field of assisted reproduction, further improve the success rate of assisted reproduction treatment, prevent and reduce birth defects, and promote the rapid development of the global reproductive health market.
The signing ceremony was attended by Mr. Somchai Wongsawat, former Prime Minister of Thailand and Mr. Tanaphol Bunwarut, Chairman of the Board of Directors and Chief Executive Officer (Acting), The Thai Setakij Insurance Public Company Limited.
DHC Medical Group wholly owns Deep & Harmonicare IVF Center, the largest single-building reproductive hospital in Bangkok, Thailand. We have a world-class advanced laboratory, which is hailed as the “Central Laboratory of the Future” by the Thai Ministry of Health. We are equipped with imported equipment from outpatient clinics, operating rooms to laboratories. We have brought together an excellent team of experts from Thailand, and adopted a multidisciplinary diagnosis and treatment model to jointly promote international development and application of advanced assisted reproductive technology.
As a leader in the field of assisted reproduction, Deep&Harmonicare IVF Center has always been at the international forefront of reproductive clinical practice, constantly creating new breakthroughs in the professional field; with its leading success rate, first-class technology and equipment, and international standard management practices, it has continuously accredited by JCI in the United States, NEQAS in the United Kingdom and other authoritative international certifications, and in-depth cooperation with the Cambridge Medical School in the United Kingdom to establish the Cambridge Medical School’s first IVF Center of Excellence in the Asia-Pacific region, and set up the “DHC Intractable Diseases International Consultation Department“.
In order to build a world-leading international assisted reproductive medical group that covers the full-cycle needs of customers, Deep & Harmonicare IVF Center has currently established a European representative office in the United Kingdom and will set up representative offices in Southeast Asia, Australia, the Middle East, Hong Kong, and other countries and regions in the future. Form a satellite network, radiate the world, and form a global customer acquisition and service network. Provide customers in different countries with full-process service follow-up before, during, and after the IVF, helping more and more customers to realize their family dreams.
As one of the world’s leading medical centers and tourist destinations, Thailand attracts clients from all over the world with assisted reproduction needs to seek medical treatment in Thailand with its first-class medical technology and equipment, affordable prices, abundant tourism resources, and looser regulations and policies travel.
Deep & Harmonicare IVF Center has been adhering to the tenet of being customer-centric and returning to the essence of medical care for many years. With its superb medical technology, leading success rate, and first-class diagnosis and treatment services, it has not only won wide recognition from local customers in Thailand, but also won more and more trust from international customers such as China, Australia, Singapore, the United Kingdom, and the Middle East.
With the completion of this round of strategic financing, DHC Medical Group will achieve leapfrog development, complete a wider international market layout as soon as possible, form a unique competitive advantage, and further consolidate and improve DHC Medical Group’s leading edge in the field of international assisted reproductive medicine.
Additional information: Deep & Harmonicare IVF Center, Infertility Consultation and Treatment Center
LINE Official Account: @dhcivf.th
Facebook Page: Deep & Harmonicare IVF Center Global
Tel: 093-7891313
About Author
